Medical Tech Company Announces First Ever GI Disorder Procedure
Motus GI Announces Groundbreaking Procedure: A Boon for Upper GI Patients.
In a recent development that has the potential to revolutionize healthcare, Motus GI Holdings, Inc., a medical technology company, has announced the successful completion of the first upper gastrointestinal (GI) patient procedure using their FDA cleared Pure-Vu® EVS Gastro. This pivotal procedure indicates a significant leap forward in the field of gastroenterology and holds immense promise for patients with upper GI disorders.
Motus GI's Pure-Vu® EVS is an innovative system designed to aid in the cleaning of a poorly prepped colon during a colonoscopy procedure. The extension of this technology to upper GI procedures represents a notable advancement in the sector.
Patients suffering from upper GI disorders often undergo invasive procedures that can be uncomfortable and, in some cases, risky. The introduction of the Pure-Vu® EVS Gastro could potentially diminish these risks, offering a safer, more efficient alternative.
Dr. David Hass, a respected gastroenterologist and Assistant Clinical Professor of Medicine at Yale University School of Medicine, performed the landmark procedure. He stated, "The Pure-Vu® EVS Gastro system's effectiveness in facilitating diagnostic and therapeutic endoscopy, despite the presence of significant residual food matter, is impressive." source
Impact on the Medical Field
This breakthrough by Motus GI is seen as a game-changer in the medical field. Not only does it offer new treatment possibilities for patients, but it also provides an opportunity for healthcare providers to enhance their service delivery.
The CEO of Motus GI, Tim Moran, expressed his enthusiasm about the successful procedure, stating, "This is a significant milestone for our company and for patients suffering from upper GI disorders. We are committed to developing technologies that improve patient outcomes and enhance the efficiency of GI procedures." source
What's Next for Motus GI?
Motus GI's success with the Pure-Vu® EVS Gastro is just the beginning. The company has plans to continue developing innovative solutions for the healthcare industry, with a particular focus on gastroenterology.
In conclusion, the successful execution of the first upper GI patient procedure using the FDA cleared Pure-Vu® EVS Gastro by Motus GI marks a significant stride in the medical field. It not only offers hope for patients dealing with upper GI disorders but also sets a new standard for healthcare providers.
Disclaimer: This article includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission. This does not influence the independence of the reporting or the integrity of the information provided.
As an investor it's important to stay updated with major news. Get real-time alerts by creating an account here.
Sources: